IGC Pharma Inc (IGC)
0.5104
-0.01
(-1.85%)
USD |
NYAM |
May 10, 16:00
0.5104
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Price to Book Value: 3.593 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 3.661 |
| May 08, 2024 | 3.800 |
| May 07, 2024 | 3.560 |
| May 06, 2024 | 3.597 |
| May 03, 2024 | 3.599 |
| May 02, 2024 | 3.661 |
| May 01, 2024 | 3.576 |
| April 30, 2024 | 3.816 |
| April 29, 2024 | 3.261 |
| April 26, 2024 | 3.224 |
| April 25, 2024 | 3.027 |
| April 24, 2024 | 3.091 |
| April 23, 2024 | 3.214 |
| April 22, 2024 | 3.134 |
| April 19, 2024 | 3.450 |
| April 18, 2024 | 3.352 |
| April 17, 2024 | 4.129 |
| April 16, 2024 | 3.422 |
| April 15, 2024 | 3.092 |
| April 12, 2024 | 3.098 |
| April 11, 2024 | 3.731 |
| April 10, 2024 | 3.738 |
| April 09, 2024 | 4.048 |
| April 08, 2024 | 4.365 |
| April 05, 2024 | 4.573 |
| Date | Value |
|---|---|
| April 04, 2024 | 4.857 |
| April 03, 2024 | 4.508 |
| April 02, 2024 | 3.77 |
| April 01, 2024 | 3.351 |
| March 28, 2024 | 2.816 |
| March 27, 2024 | 2.862 |
| March 26, 2024 | 2.809 |
| March 25, 2024 | 2.816 |
| March 22, 2024 | 2.647 |
| March 21, 2024 | 2.394 |
| March 20, 2024 | 2.425 |
| March 19, 2024 | 2.663 |
| March 18, 2024 | 2.387 |
| March 15, 2024 | 2.284 |
| March 14, 2024 | 2.368 |
| March 13, 2024 | 2.344 |
| March 12, 2024 | 2.289 |
| March 11, 2024 | 2.341 |
| March 08, 2024 | 2.345 |
| March 07, 2024 | 2.323 |
| March 06, 2024 | 2.312 |
| March 05, 2024 | 2.361 |
| March 04, 2024 | 2.457 |
| March 01, 2024 | 2.464 |
| February 29, 2024 | 2.426 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3983
Minimum
Mar 18 2020
6.550
Maximum
Feb 10 2021
1.706
Average
1.412
Median
Aug 31 2023
Price to Book Value Benchmarks
| CEL-SCI Corp | 6.059 |
| AIM ImmunoTech Inc | 2.108 |
| NovaBay Pharmaceuticals Inc | 1.774 |
| Protalix BioTherapeutics Inc | 2.416 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 23.52 |
| Price | 0.5104 |
| Earnings Yield | -50.94% |
| Market Cap | 32.53M |